Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Initial study in children with epilepsy to evaluate the pharmacokinetics, safety,
tolerability and preliminary efficacy of adjunctive treatment with brivaracetam, and to
develop dosing adaptations for future studies.